Margins matter. The more BioScrip (NAS: BIOS) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders.
Margins matter. The more BioScrip (NAS: BIOS) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders.
Margins matter. The more BioScrip (NAS: BIOS) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders.
It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?" When judging a company's prospects, how ...
Shares of the home infusion services giant BioScrip (NASDAQ: BIOS) jumped by almost 40% in premarket trading today. Once the market opened, however, the company's stock abruptly reversed course, ...
BioScrip (Nasdaq: BIOS) reported earnings on May 10. Here are the numbers you need to know. The 10-second takeaway For the quarter ended March 31 (Q1), BioScrip beat expectations on revenues and ...
A month has gone by since the last earnings report for BioScrip (BIOS). Shares have added about 18.7% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What's happening: ...
Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are ...
ELMSFORD, N.Y.--(BUSINESS WIRE)--BioScrip, Inc. (Nasdaq: BIOS) today announced that it has completed its acquisition of Critical Homecare Solutions Holdings, Inc. (“CHS”), a leading provider of home ...
Shares of the home infusion services giant BioScrip (NASDAQ: BIOS) jumped by almost 40% in premarket trading today. Once the market opened, however, the company's stock abruptly reversed course, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results